• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE MOLECULAR SYSTEMS COBAS 4800 BRAF V600 MUTATION TEST; SOMATIC GENE MUTATION DETECTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE MOLECULAR SYSTEMS COBAS 4800 BRAF V600 MUTATION TEST; SOMATIC GENE MUTATION DETECTION SYSTEM Back to Search Results
Catalog Number 05985595190
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/03/2017
Event Type  Injury  
Manufacturer Narrative
A customer from (b)(6) alleged discrepant results received from the cobas braf mutation test and a sequencing test.A positive result was seen during a braf genotyping test with qpcr and sequencing.However, a no mutation detected result was generated when testing twice with the cobas 4800 braf v600 mutation test on (b)(6) 2017.The affiliate indicated because of the different results obtained from the braf mutation test and the sequencing test, the patient did not yet receive treatment.Review of the provided data on the cobas braf mutation test showed no ct values were seen for the mutant target.The wild-type (wt) ct values in both initial and repeat test showed delayed ct values that indicate a poor quality sample.As the wt ct value for the initial and repeat run indicate a poor quality sample and the controls were valid and within range, the issue at the site is likely sample specific.It is possible that the alleged sample is at the limit of detection (lod) of the test, the dna is highly degraded or has high amount of melanin in it (if it is skin sample because it interferes in pcr); therefore, the test would be difficult to detect the mutation.In addition, it is not known what frequency of mutation was observed in the sequencing test as the frequency of mutation might also affect the detection of mutation in a sample.Internal investigation on the complaint kit lots (w09521 and w12410) found the kit lots to meet specifications with no product problem found as no related non conformance was found in qc release data and no complaint trend was observed for these complaint kit lots.Medical affairs indicated that the risk of a false negative is that the patient won't be treated with vemurafinib or vem/tremetininb which could potentially prolong their life by 8-16 months depending upon the therapy.They would then be treated with other immunotherapy drugs such as pemborlizumab, but it would have an impact on survival as chemotherapy has it's toxicities and will only provide a few months of survival at best.However, if the mutation frequency is very low, it is unknown how effective v600e directed therapy would be.This mdr is filed for the reagent lot w12410 used in testing on (b)(6) 2017.Another mdr is filed for the reagent lot w09521 used in testing on (b)(6) 2017.The udi for the kit c4800 braf v600e amp/det 24t ce-ivd is (b)(4).The corresponding us kit material number is (b)(4) and its udi number is (b)(4).The facility name of the initial reported was truncated due to character limitations.The complete facility name is (b)(4).(b)(4).
 
Event Description
A patient from (b)(6) alleged discrepant results received from the cobas braf mutation test and a sequencing test.A positive result was seen during a braf genotyping test with qpcr and sequencing.However, a no mutation detected result was generated when testing twice with the cobas 4800 braf v600 mutation test on (b)(6) 2017 with 2 different reagent lots.The affiliate indicated because of the different results obtained from the braf mutation test and the sequencing test, the patient did not yet receive treatment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS 4800 BRAF V600 MUTATION TEST
Type of Device
SOMATIC GENE MUTATION DETECTION SYSTEM
Manufacturer (Section D)
ROCHE MOLECULAR SYSTEMS
1080 us highway 202 south
branchburg NJ 08876
Manufacturer Contact
stacie-ann creighton
1080 us hwy 202 s
na
branchburg, NJ 08876
9082537112
MDR Report Key6451114
MDR Text Key71467011
Report Number2243471-2017-00009
Device Sequence Number1
Product Code OWD
Combination Product (y/n)N
Reporter Country CodeTU
PMA/PMN Number
P110020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Health Professional
Type of Report Initial
Report Date 03/31/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/28/2017
Device Catalogue Number05985595190
Device Lot NumberW12410
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/03/2017
Initial Date FDA Received03/31/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
-
-